Supplementary Tables 1-4 from Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses

2026 Open access

Read full text
Authors: Dimitrios N. Sidiropoulos, Zhehao Zhang, Jennifer N. Durham, Soren Charmsaz, Nicole Groß, Jae Sung Lee, Yanyi Sun, Susheel Perikala, Joseph A. Tandurella, Dmitrijs Lvovs, A. W. Mitschang, Gerard Lemson
+11 more Sarah M. Shin, Alexei Hernandez, Sarah Mitchell, James M. Leatherman, Ludmila Danilova, Hao Wang, Elana Judith Fertig, Elizabeth M. Jaffee, Katherine M. Bever, Dung Thi Le, Won Jin Ho
DOI: 10.1158/2326-6066.31483943
Cited by: 0

Abstract

Supplementary Table 1. Number of samples per trial arm, timepoints, and clinical metadata. SD: Stable Disease, PD: Progressive Disease, PR: Partial response. Supplementary Table 2. T cell focused CyTOF Panel. Supplementary Table 3. Myeloid CyTOF Panel. Supplementary Table 4. IMC Panel.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Pancreatic and Hepatic Oncology Research Diabetes and associated disorders

Publication details

Publication date
4 March 2026
Language
EN